Evidence mapPaperPMID 34829629Full record

ReviewAntioxidants (Basel, Switzerland)2021

Physical Exercise Potentially Targets Epicardial Adipose Tissue to Reduce Cardiovascular Disease Risk in Patients with Metabolic Diseases: Oxidative Stress and Inflammation Emerge as Major Therapeutic Targets.

Thembeka A Nyawo, Carmen Pheiffer, Sithandiwe E Mazibuko-Mbeje, Sinenhlanhla X H Mthembu, Tawanda M Nyambuya, Bongani B Nkambule, Hanél Sadie-Van Gijsen, Hans Strijdom, Luca Tiano, Phiwayinkosi V Dludla

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. A Review on the Antidiabetic Properties ofFrontiers in pharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Thembeka A NyawoBiomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7505, South Africa.
Carmen PheifferBiomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7505, South Africa.ORCID 0000-0002-0707-1552
Sithandiwe E Mazibuko-MbejeDepartment of Biochemistry, North-West University, Mafikeng Campus, Mmabatho 2735, South Africa.
Sinenhlanhla X H MthembuBiomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7505, South Africa.ORCID 0000-0003-2747-1841
Tawanda M NyambuyaDepartment of Health Sciences, Faculty of Health and Applied Sciences, Namibia University of Science and Technology, Windhoek 9000, Namibia.ORCID 0000-0002-3288-9524
Bongani B NkambuleSchool of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa.
Hanél Sadie-Van GijsenCentre for Cardiometabolic Research in Africa (CARMA), Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa.ORCID 0000-0002-1745-563X
Hans StrijdomCentre for Cardiometabolic Research in Africa (CARMA), Division of Medical Physiology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South Africa.ORCID 0000-0003-3726-9153
Luca TianoDepartment of Life and Environmental Sciences, Polytechnic University of Marche, 60131 Ancona, Italy.ORCID 0000-0002-7519-7106
Phiwayinkosi V DludlaBiomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7505, South Africa.ORCID 0000-0001-5965-3610
South African Medical Research Council · ZAStellenbosch University · ZAMarche Polytechnic University · ITNamibia University of Science and Technology · NANorth-West University · ZAUniversity of KwaZulu-Natal · ZA

Funding

National Research Foundation 117829
6 · The paper itself

Abstract

Excess epicardial adiposity, within a state of obesity and metabolic syndrome, is emerging as an important risk factor for the development of cardiovascular diseases (CVDs). Accordingly, increased epicardial fat thickness (EFT) implicates the exacerbation of pathological mechanisms involving oxidative stress and inflammation within the heart, which may accelerate the development of CVDs. This explains increased interest in targeting EFT reduction to attenuate the detrimental effects of oxidative stress and inflammation within the setting of metabolic syndrome. Here, we critically discuss clinical and preclinical evidence on the impact of physical exercise on EFT in correlation with reduced CVD risk within a setting of metabolic disease. This review also brings a unique perspective on the implications of oxidative stress and inflammation as major pathological consequences that link increased EFT to accelerated CVD risk in conditions of metabolic disease.

Indexed as

cardiovascular diseaseepicardial adipose tissueexerciseinflammationoxidative stressphysical activity

Identifiers

PMID34829629
PMCPMC8614861
OpenAlexW3210041290

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.